Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GNGBY Getinge	$20.22 +1.9%	$19.48	$14.84 ▼ $22.85	N/A	1.09	8,352 shs	3,449 shs
MASI Masimo	$162.35 -0.1%	$161.84	$101.61 ▼ $194.88	$8.81B	1.19	642,093 shs	868,113 shs
MDT Medtronic	$88.63 +1.1%	$85.45	$75.96 ▼ $96.25	$112.44B	0.8	7.00 million shs	5.40 million shs
SONVY SONOVA	$58.28 +0.5%	$62.10	$52.83 ▼ $77.56	$17.29B	1.28	12,781 shs	17,884 shs
VAR Varian Medical Systems	$177.07	$177.00	$103.67 ▼ $177.38	$16.26B	1.06	746,779 shs	N/A

10 Stocks Set to Soar in Summer 2025

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GNGBY Getinge	+1.92%	+1.76%	+3.48%	+6.42%	+15.87%
MASI Masimo	-0.06%	-3.94%	-5.59%	-1.35%	+44.12%
MDT Medtronic	+1.03%	-0.06%	+1.43%	+3.76%	+15.34%
SONVY SONOVA	+0.48%	-3.14%	-6.50%	+2.84%	-4.44%
VAR Varian Medical Systems	0.00%	0.00%	0.00%	0.00%	0.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
GNGBY Getinge	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MASI Masimo	4.3418 of 5 stars	3.4	1.0	0.0	4.2	2.3	3.3	1.3
MDT Medtronic	4.8947 of 5 stars	3.3	3.0	3.3	4.1	3.5	1.7	1.9
SONVY SONOVA	1.7243 of 5 stars	0.0	3.0	1.7	0.0	2.3	0.0	1.9
VAR Varian Medical Systems	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GNGBY Getinge	2.00	Hold	N/A	N/A
MASI Masimo	2.83	Moderate Buy	$191.60	18.02% Upside
MDT Medtronic	2.63	Moderate Buy	$98.00	10.57% Upside
SONVY SONOVA	1.50	Reduce	N/A	N/A
VAR Varian Medical Systems	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest MDT, VAR, SONVY, MASI, and GNGBY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/8/2025	MDT Medtronic	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$103.00 ➝ $106.00
6/30/2025	MDT Medtronic	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underperform ➝ Peer Perform
6/20/2025	SONVY SONOVA	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
6/17/2025	GNGBY Getinge	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
6/16/2025	MDT Medtronic	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/16/2025	MDT Medtronic	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$110.00
6/11/2025	SONVY SONOVA	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Strong Sell
6/6/2025	MDT Medtronic	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
6/6/2025	SONVY SONOVA	Kepler Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
5/22/2025	MDT Medtronic	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$100.00 ➝ $98.00
5/22/2025	MDT Medtronic	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$105.00 ➝ $101.00

(Data available from 7/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GNGBY Getinge	$3.29B	N/A	$1.63 per share	12.43	$10.53 per share	N/A
MASI Masimo	$2.09B	4.20	$6.38 per share	25.43	$19.50 per share	8.33
MDT Medtronic	$33.54B	3.39	$7.84 per share	11.31	$37.62 per share	2.36
SONVY SONOVA	$4.36B	3.98	$3.42 per share	17.02	$10.16 per share	5.74
VAR Varian Medical Systems	$3.17B	5.13	$5.07 per share	34.94	$22.92 per share	7.73

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GNGBY Getinge	$154.96M	$0.51	39.65	∞	N/A	4.15%	10.24%	5.40%	7/18/2025 (Estimated)
MASI Masimo	-$304.90M	-$9.17	N/A	35.06	N/A	-25.06%	22.56%	10.00%	8/5/2025 (Estimated)
MDT Medtronic	$4.66B	$3.62	24.48	15.20	2.37	13.90%	14.54%	7.83%	8/19/2025 (Estimated)
SONVY SONOVA	$610.01M	N/A	0.00	21.91	2.27	N/A	N/A	N/A	N/A
VAR Varian Medical Systems	$269.20M	$3.91	60.43	30.11	N/A	8.50%	18.45%	8.08%	N/A

Latest MDT, VAR, SONVY, MASI, and GNGBY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2025	Q2 2025	MASI Masimo	$1.23	N/A	N/A	N/A	$368.65 million	N/A
5/21/2025	Q4 2025	MDT Medtronic	$1.58	$1.62	+$0.04	$0.82	$8.81 billion	$8.93 billion
5/6/2025	Q1 2025	MASI Masimo	$1.24	$1.36	+$0.12	-$3.12	$367.79 million	$372.00 million
4/22/2025	Q1 2025	GNGBY Getinge	N/A	$0.20	N/A	$0.10	N/A	$779.56 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
GNGBY Getinge	$0.28	1.38%	N/A	54.90%	N/A
MASI Masimo	N/A	N/A	N/A	N/A	N/A
MDT Medtronic	$2.84	3.20%	N/A	78.45%	49 Years
SONVY SONOVA	$0.63	1.08%	N/A	N/A	N/A
VAR Varian Medical Systems	N/A	N/A	N/A	N/A	N/A

Latest MDT, VAR, SONVY, MASI, and GNGBY Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/21/2025	MDT Medtronic	quarterly	$0.71	3.3%	6/27/2025	6/27/2025	7/11/2025
6/14/2025	SONVY SONOVA		$0.6243	0.99%	6/16/2025	6/17/2025	7/2/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GNGBY Getinge	0.05	0.84	0.53
MASI Masimo	0.67	2.17	1.62
MDT Medtronic	0.53	1.85	1.42
SONVY SONOVA	0.45	1.27	0.96
VAR Varian Medical Systems	N/A	1.40	1.13

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GNGBY Getinge	N/A
MASI Masimo	85.96%
MDT Medtronic	82.06%
SONVY SONOVA	0.01%
VAR Varian Medical Systems	86.96%

Insider Ownership

Company	Insider Ownership
GNGBY Getinge	N/A
MASI Masimo	16.90%
MDT Medtronic	0.20%
SONVY SONOVA	0.01%
VAR Varian Medical Systems	0.78%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GNGBY Getinge	11,791	N/A	N/A	Not Optionable
MASI Masimo	5,600	54.22 million	45.06 million	Optionable
MDT Medtronic	95,000	1.28 billion	1.28 billion	Optionable
SONVY SONOVA	17,990	298.13 million	298.10 million	Not Optionable
VAR Varian Medical Systems	10,000	91.84 million	N/A	Optionable

MDT, VAR, SONVY, MASI, and GNGBY Headlines

Recent News About These Companies

Varian’s Benefit From Prior Dividend Ruling Limited, IRS Argues

June 9, 2025 | news.bloomberglaw.comN

CESTAT Orders Refund of SAD on the basis of TR-6 Challan Evidence

May 15, 2025 | taxguru.inT

Siemens Healthineers relocates Varian’s Mexico manufacturing to the US

May 14, 2025 | medicaldevice-network.comM

Agreement Between Varian and Embolx Paves the Way for Advanced Image-Guided Therapies for Cancer

March 28, 2025 | finance.yahoo.com

Northwell radiation centers first on Long Island with Varian Ethos HyperSight

March 18, 2025 | tbrnewsmedia.comT

Leadership Success Story Of Pavan Kanchi's Varian Medical Systems Transformation

March 3, 2025 | outlookindia.com

UH Seidman Cancer Center introduces advanced Varian Ethos 2.0 for cancer treatment

January 24, 2025 | msn.com

Gleneagles HK and Varian partner to promote radiation oncology training

January 14, 2025 | msn.com

Medical Robot Industry Forecast Robust Growth USD 38701.5 Million with 12.9% CAGR Expected Through 2034

January 1, 2025 | pharmiweb.comP

Varian’s RapidArc Dynamic Solution Unlocks New Dimensions in Treatment Planning and Delivery

December 18, 2024 | businesswire.com

Portneuf Cancer Center to host community ribbon cutting for new linear accelerator

November 14, 2024 | idahostatejournal.comI

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

November 14, 2024 | msn.com

Varian Medical Ruling Shows Loper Bright Case's Continued Power

November 14, 2024 | news.bloomberglaw.comN

BVHS Acquires Linear Accelerator For Cancer Treatments

November 7, 2024 | wfin.comW

Siemens Announces $10.6 Bn Acquisition of Altair Engineering Inc

November 1, 2024 | indianweb2.comI

Opinion - On AI policy, why is the UK desperate to appease authoritarian vendors?

October 30, 2024 | diginomica.comD

Envision shakes up C-suite

October 29, 2024 | beckershospitalreview.comB

Recent Supreme Court Decisions May Affect Tax Practice

October 23, 2024 | law.comL

Radiation Oncology Market Size Worth $23.62 Billion, Globally, by 2031 - Exclusive Report by The Insight Partners

October 16, 2024 | prnewswire.co.ukP

REIT Tax News - October 2024

October 8, 2024 | jdsupra.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
3 Safe Buy-and-Hold Dividend Stocks With Strong Balance Sheets
By Chris Markoch | July 1, 2025
View 3 Safe Buy-and-Hold Dividend Stocks With Strong Balance Sheets
Texas Instruments Stock: Congress Likes It, Should You Too?
By Thomas Hughes | June 24, 2025
View Texas Instruments Stock: Congress Likes It, Should You Too?

MDT, VAR, SONVY, MASI, and GNGBY Company Descriptions

Getinge OTCMKTS:GNGBY

$20.22 +0.38 (+1.92%)

As of 07/8/2025 03:59 PM Eastern

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Masimo NASDAQ:MASI

$162.35 -0.10 (-0.06%)

Closing price 07/8/2025 04:00 PM Eastern

Extended Trading

$162.49 +0.14 (+0.09%)

As of 07/8/2025 06:15 PM Eastern

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Medtronic NYSE:MDT

$88.63 +0.96 (+1.10%)

Closing price 07/8/2025 03:59 PM Eastern

Extended Trading

$89.01 +0.38 (+0.43%)

As of 07/8/2025 08:00 PM Eastern

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

SONOVA OTCMKTS:SONVY

$58.28 +0.28 (+0.48%)

As of 07/8/2025 03:59 PM Eastern

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.

Varian Medical Systems NYSE:VAR

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, artificial intelligence based adaptive radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy afterloaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with McKesson Corp. to supply treatment delivery systems and planning, services, and radiotherapy information system solutions to its U.S. Oncology Network and Vantage Oncology affiliated sites of care; and a strategic partnership with Siemens AG to represent Siemens diagnostic imaging products to radiation oncology clinics in the United States and other select markets. Varian Medical Systems, Inc. was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?